Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin in Systemic Lupus Erythematosus
NCT00432354Phase 3Unknown
- Sponsor
- Buddhist Tzu Chi General Hospital
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of atorvastatin in systemic lupus erythematosus (SLE) (2 arms), sponsored by Buddhist Tzu Chi General Hospital. Primary endpoint: Systemic Lupus Erythematosus Disease Activity Index at 6 months. Status: unknown.
02
Drugs
atorvastatin
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT00432354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00432354.